Cynomolgus monkey model of interleukin‐31‐induced scratching depicts blockade of human interleukin‐31 receptor A by a humanized monoclonal antibody

Publisher： John Wiley & Sons Inc

E-ISSN： 1600-0625|27|1|14-21

ISSN： 0906-6705

Source： EXPERIMENTAL DERMATOLOGY (ELECTRONIC), Vol.27, Iss.1, 2018-01, pp. : 14-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emerging role of interleukin‐31 and interleukin‐31 receptor in pruritus in atopic dermatitis

By  

ALLERGY, Vol. 73, Iss. 1, 2018-01 ,pp. : 29-36

John Wiley & Sons Inc

Access to resources Recommend Favorite

Molecular Cloning and Expression of Cynomolgus Monkey Interleukin -1β cDNA

By  

International Archives of Allergy and Immunology, Vol. 116, Iss. 1, 2009-07 ,pp. : 40-48

Karger

Access to resources Recommend Favorite

Tocilizumab: A novel humanized anti-interleukin 6 (IL-6) receptor antibody for the treatment of patients with non-RA systemic, inflammatory rheumatic diseases

By Alten Rieke   Maleitzke Tazio  

Annals of Medicine, Vol. 45, Iss. 4, 2013-06 ,pp. : 357-363

Informa Healthcare

Access to resources Recommend Favorite

Upregulation of Interleukin-13 and Its Receptor in a Murine Model of Bleomycin-Induced Scleroderma

By  

International Archives of Allergy and Immunology, Vol. 135, Iss. 4, 2004-12 ,pp. : 348-356

Karger

Access to resources Recommend Favorite

Non‐Clinical Pharmacokinetics, Prediction of Human Pharmacokinetics and First‐in‐Human Dose Selection for CNTO 5825, an Anti‐Interleukin‐13 Monoclonal Antibody

By  

BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol. 117, Iss. 4, 2015-10 ,pp. : 219-225

John Wiley & Sons Inc

Access to resources Recommend Favorite